At no point on Thursday did anyone from the administration mention Medicare drug price negotiations, a key part of the ...

Medicare has selected the technology vendors who'll run its prior authorization pilot in New Jersey, Ohio, Oklahoma, Texas, ...

WASHINGTON — The Trump administration’s deal to expand access to and lower the cost of weight loss drugs has left industry ...

The FDA announced the second batch of companies being granted a “Commissioner’s National Priority Voucher,” a ticket to ...

On this week’s episode of "The Readout LOUD," melodrama at the top of the FDA and the latest on the Pfizer-Novo Nordisk ...

A federal judge in Rhode Island ordered the Trump administration Thursday to find the money to fully fund SNAP benefits for ...

Leading scientists and bioethicists are urging the creation of an international oversight body to monitor advances in human ...

Pfizer is preparing to sweeten its offer again for Metsera, the weight loss drug startup at the center of a bidding war with ...

Biotech investors have not often looked at a balding head of hair and been struck with inspiration, even on the rare ...

If Congress does extend the enhanced subsidies into next year, policymakers and insurance companies can do a few things to ...

The J&J antipsychotic drug Caplyta won FDA approval for depression, a broader indication that could help the medicine become ...

The complete response letter has not yet been posted to the FDA website, but according to Biohaven, the agency rejected its ...